Anaptysbio (ANAB) EBITDA Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,003.00 |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | 286,944.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 286,944.00 |
| Dec 31, 2025 | 57,910.00 |
| Sep 30, 2025 | 278,733.00 |
| Jun 30, 2025 | 262,022.00 |
| Mar 31, 2025 | 380,291.00 |
| Dec 31, 2024 | 315,140.00 |
| Sep 30, 2024 | -17,773.00 |
| Jun 30, 2024 | -42,093.00 |
| Mar 31, 2024 | -42,690.00 |
| Dec 31, 2023 | -50,714.00 |
| Mar 31, 2023 | -300,231.00 |
| Dec 31, 2022 | 16,713.00 |
| Jun 30, 2022 | -232,265.00 |
| Sep 30, 2021 | 28,299.00 |
| Dec 31, 2020 | 29,710.00 |
| Dec 31, 2019 | -25,427.00 |
| Jun 30, 2019 | -47,636.00 |